Supported by      

Critical Care Reviews Newsletter

Newsletter 489  |  April 25th 2021

Register for the free weekly newsletter

Welcome to the 489th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.

The highlights of this week's edition are randomised controlled trials on suvratoxumab for the prevention of Staphylococcus aureus ventilator-associated pneumonia & aspirin versus anticoagulation in cervical artery dissection; systematic reviews and meta analyses on refeeding syndrome & corticosteroids in COVID-19 and non-COVID-19 ARDS; and observational studies on the impact of frailty on survival in elderly intensive care patients with COVID-19 & death in hospital following ICU discharge: insights from the LUNG SAFE study.

There are also narrative reviews on embolization in trauma & long-term outcomes and the post-intensive care syndrome in critically ill children; an editorial on ventilator-associated pneumonia in the era of COVID-19 pandemic; and commentaries on gender imbalance in intensive care & remote research and clinical trial integrity during and after the Coronavirus pandemic; as well as correspondence on emergency intubation in Covid-19 & cytokine storm

If you only have time to read one article this week, try this one on nasal potential difference in patients with, and at risk of, acute respiratory distress syndrome. Ok, I'm slightly biased....

I hope you find this newsletter useful.


Until next week

Rob

 

 

Supported by the Health Research Board

 

 

Promoting Open Access to Scientific Advancement
Supported by      


© All rights reserved.

Back to Top